This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Biopolymed Inc.. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: The Innovative Contributions of Kyung-A Kim
Introduction
Kyung-A Kim is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic solutions targeting cell proliferation and migration.
Latest Patents
Kyung-A Kim holds a patent for "siRNA of NF-kB p105 for inhibiting cell proliferation and migration and a composition comprising same." This invention relates to a small interfering RNA (siRNA) that targets the mRNA of the NF-Kappa B p105 gene, leading to its degradation through RNA interference (RNAi) induction. The patent also includes a pharmaceutical composition designed for treating diseases associated with abnormal cell proliferation and migration, which comprises the siRNA and a delivery vehicle capable of facilitating intracellular delivery.
Career Highlights
Kyung-A Kim is currently associated with Biopolymed Inc., where he continues to advance his research and innovations. His work focuses on developing novel therapeutic strategies that can have a profound impact on medical treatments.
Collaborations
Kyung-A Kim collaborates with esteemed colleagues, including Myung-Ok Park and Choun-Ki Joo, who contribute to his research endeavors and help enhance the scope of his inventions.
Conclusion
Kyung-A Kim's innovative work in biotechnology exemplifies the potential of siRNA technology in addressing critical health challenges. His contributions are paving the way for new therapeutic approaches in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile